Namrata Saroj, OD is an independent consultant with over 20 years of experience focusing on developing new drugs and technologies for advancing ophthalmic care. Prior to this, she led Ophthalmology Medical Affairs as an Executive Director at Regeneron Pharmaceuticals, Inc supporting the commercialization of EYLEA and was involved in strategic planning and activities supporting new ophthalmology products in development. Prior to joining Regeneron, Namrata held positions at Genentech in a field-based Medical Affairs function supporting Lucentis. She started her career as a Research Associate at the Manhattan Eye, Ear & Throat Hospital focusing on clinical trials in retinal diseases. Namrata has successfully supported multiple investigator-initiated studies and research collaborations as well as co-authored multiple publications in management of retinal diseases. Namrata earned her Doctor of Optometry from the University of California at Berkeley. She holds a Bachelor of Science in Optometry from the University of California and a Bachelor of Arts in Biochemistry from Whittier College.